MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Plasma proteomic profiles and risk of Parkinson’s disease: a prospective study from UK Biobank

    C. Li, B. Ke, X. Zheng, Y. Xiao, S. Wang, Q. Jiang, J. Lin, J. Huang, H. Shang (Chengdu, China)

    Objective: To identify proteins associated with risk of Parkinson's disease (PD). Background: Alterations in plasma protein levels manifest early in individuals at risk of PD.…
  • 2025 International Congress

    Clustering and Identification of Parkinson’s Disease Severity Subtypes Using Multimodal Data and Machine Learning Approaches

    H. Park, C. Youm, H. Choi, J. Hwang, M. Kim (Busan, Republic of Korea)

    Objective: This study aimed to classify Parkinson’s disease (PD) severity subtypes by integrating objective multimodal data with machine learning (ML) techniques. We applied unsupervised clustering…
  • 2025 International Congress

    Parkinson’s disease motor phenotypes delineated by pallidal and subthalamic neurophysiology and machine learning

    V. Lavu, P. Coutinho, J. Hilliard, K. Foote, C. de Hemptinne, J. Wong, K. Johnson (Gainesville, USA)

    Objective: The objective of this study was to develop a machine learning (ML) algorithm capable of predicting motor phenotypes in Parkinson's disease (PD) using intraoperative…
  • 2025 International Congress

    Machine Learning Model using Eye Movements for the Differential Diagnosis of iPD and Atypical Parkinsonian Syndromes

    A. Sekar, D. Kaski (London, United Kingdom)

    Objective: To develop a machine learning (ML) model to first between differentiate between healthy controls, idiopathic PD, Atypical Parkinsonian syndromes and then further subclassify as…
  • 2025 International Congress

    Patient-Reported Satisfaction and Usability of a Virtual Home-Based Program for Fall Prevention in Parkinson’s Disease

    S. Dharmadhikari, V. Palakuzhy, Y. Kianirad, M. Afshari (Chicago, USA)

    Objective: To evaluate participant perspectives and satisfaction with a virtual home safety intervention to reduce environmental fall risks in persons with Parkinson’s disease (PwPs). Background: While…
  • 2025 International Congress

    Investigating the Role of Age and Neurological Status on Adaptive Balance Strategies: A Systematic Review Utilizing Big Data Techniques

    N. Ali, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah, M. M. Elsayed (Mansoura, Egypt)

    Objective: To examine the influence of age and neurological status on adaptive balance strategies using big data analytics and systematic review methodologies. Background: Balance control…
  • 2025 International Congress

    Long-Term Effect of Dopaminergic Treatment on gait in De Novo Parkinson’s Disease: the DNA mobile health technology longitudinal study

    A. Pilotto, C. Zatti, A. Rizzardi, C. Hansen, J. Gerritz, R. Romijnders, M. Catania, A. Lupini, W. Maetzler, A. Padovani (Brescia, Italy)

    Objective: to evaluate the long-term effect of dopaminergic treatment on gait in Parkinson’s disease Background: monitoring the progression of Parkinson's disease (PD) and response to…
  • 2025 International Congress

    Patterns and Predictors of Cholinesterase Inhibitor Use in Dementia with Lewy Bodies

    R. Heo, A. Negida, K. Wyman-Chick, J. Bateman, F. Rodriguez-Porcel, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: The objective of this study was to identify the patterns and predictors of cholinesterase inhibitor (ChEI) prescribing in Dementia with Lewy bodies (DLB) patients.…
  • 2025 International Congress

    Modulation of working memory in prodromal DLB by non-invasive brain stimulation of the striatum and cerebellum

    I. Rektorová, M. Pupikova, . Gajdoš (Brno, Czech Republic)

    Objective: We aimed to modulate working memory (WM) in patients with MCI with Lewy bodies (MCI-LB) by non-invasive stimulation of the striatum with or without…
  • 2025 International Congress

    Carbidopa/levodopa related hypotension in patients with alpha-synucleinopathies

    D. Rebolledo, JA. Romero-Mera, JC. Lopez-Hernandez, M. Groccopatel-Marra, A. Gonzalez-Duarte, P. Millar Vernetti, H. Kaufmann (New York, USA)

    Objective: Evaluate blood pressure response to levodopa/carbidopa in patients with synucleinopathies undergone to autonomic testing. Background: Carbidopa/levodopa is the mainstay treatment of patients with synucleinopathies,…
  • « Previous Page
  • 1
  • …
  • 168
  • 169
  • 170
  • 171
  • 172
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley